Concepts (204)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Receptors, Dopamine D1 | 30 | 2019 | 85 | 6.960 |
Why?
|
| Oxidative Stress | 32 | 2020 | 795 | 4.850 |
Why?
|
| Kidney Tubules, Proximal | 24 | 2020 | 109 | 4.110 |
Why?
|
| Kidney | 16 | 2020 | 1335 | 2.460 |
Why?
|
| Hypertension | 17 | 2020 | 1287 | 2.300 |
Why?
|
| Sodium-Potassium-Exchanging ATPase | 18 | 2019 | 98 | 2.040 |
Why?
|
| Natriuresis | 11 | 2019 | 37 | 1.930 |
Why?
|
| 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine | 21 | 2019 | 39 | 1.600 |
Why?
|
| Rats | 36 | 2019 | 3653 | 1.510 |
Why?
|
| Receptor, Angiotensin, Type 1 | 9 | 2014 | 60 | 1.400 |
Why?
|
| Rats, Sprague-Dawley | 19 | 2019 | 1213 | 1.390 |
Why?
|
| Dopamine | 9 | 2019 | 282 | 1.370 |
Why?
|
| Antioxidants | 14 | 2020 | 338 | 1.350 |
Why?
|
| Protein Kinase C | 10 | 2009 | 150 | 1.330 |
Why?
|
| Blood Pressure | 12 | 2020 | 1325 | 1.300 |
Why?
|
| Dopamine Agonists | 15 | 2019 | 79 | 1.290 |
Why?
|
| beta-Adrenergic Receptor Kinases | 6 | 2007 | 26 | 1.220 |
Why?
|
| Cyclic N-Oxides | 10 | 2020 | 30 | 1.120 |
Why?
|
| Sodium-Hydrogen Exchangers | 5 | 2019 | 40 | 1.080 |
Why?
|
| Sodium Chloride, Dietary | 3 | 2019 | 37 | 1.030 |
Why?
|
| Angiotensin II | 4 | 2011 | 161 | 1.020 |
Why?
|
| NF-E2-Related Factor 2 | 7 | 2020 | 102 | 0.970 |
Why?
|
| Nitric Oxide | 6 | 2018 | 439 | 0.960 |
Why?
|
| Aging | 8 | 2012 | 1176 | 0.950 |
Why?
|
| Cyclic GMP-Dependent Protein Kinases | 3 | 2019 | 14 | 0.860 |
Why?
|
| Buthionine Sulfoximine | 9 | 2020 | 28 | 0.830 |
Why?
|
| Hypertension, Renal | 2 | 2015 | 37 | 0.800 |
Why?
|
| Signal Transduction | 11 | 2020 | 4490 | 0.780 |
Why?
|
| Sodium | 4 | 2019 | 291 | 0.760 |
Why?
|
| Diuresis | 4 | 2019 | 58 | 0.740 |
Why?
|
| Insulin | 9 | 2010 | 1200 | 0.730 |
Why?
|
| Oxidants | 4 | 2014 | 25 | 0.680 |
Why?
|
| Nephritis | 1 | 2019 | 20 | 0.680 |
Why?
|
| Spin Labels | 10 | 2020 | 39 | 0.670 |
Why?
|
| NF-kappa B | 6 | 2014 | 457 | 0.670 |
Why?
|
| Animals | 42 | 2020 | 33794 | 0.660 |
Why?
|
| Angiotensin I | 1 | 2019 | 10 | 0.660 |
Why?
|
| GTP-Binding Proteins | 5 | 2009 | 171 | 0.620 |
Why?
|
| Mesenteric Arteries | 1 | 2018 | 56 | 0.580 |
Why?
|
| Receptors, G-Protein-Coupled | 1 | 2019 | 279 | 0.560 |
Why?
|
| Cell Adhesion Molecules | 1 | 2018 | 224 | 0.540 |
Why?
|
| Obesity | 6 | 2007 | 2227 | 0.540 |
Why?
|
| Phosphorylation | 9 | 2018 | 1608 | 0.530 |
Why?
|
| Kidney Tubules | 2 | 2006 | 82 | 0.530 |
Why?
|
| Microfilament Proteins | 1 | 2018 | 276 | 0.520 |
Why?
|
| Phosphoproteins | 1 | 2018 | 399 | 0.520 |
Why?
|
| Peptide Fragments | 1 | 2019 | 747 | 0.500 |
Why?
|
| Type C Phospholipases | 3 | 2011 | 27 | 0.460 |
Why?
|
| Up-Regulation | 3 | 2014 | 862 | 0.450 |
Why?
|
| Gastrins | 1 | 2013 | 33 | 0.440 |
Why?
|
| Thiazolidinediones | 2 | 2004 | 79 | 0.410 |
Why?
|
| Male | 35 | 2020 | 60091 | 0.400 |
Why?
|
| Vasodilation | 2 | 2018 | 191 | 0.390 |
Why?
|
| Epithelial Cells | 3 | 2020 | 899 | 0.390 |
Why?
|
| Serine | 5 | 2018 | 172 | 0.390 |
Why?
|
| Malondialdehyde | 6 | 2011 | 35 | 0.380 |
Why?
|
| Sodium-Hydrogen Exchanger 3 | 4 | 2013 | 12 | 0.380 |
Why?
|
| Rats, Zucker | 7 | 2010 | 41 | 0.380 |
Why?
|
| Sodium Chloride | 2 | 2009 | 95 | 0.370 |
Why?
|
| Guanosine 5'-O-(3-Thiotriphosphate) | 7 | 2012 | 26 | 0.370 |
Why?
|
| Inflammation | 4 | 2020 | 1401 | 0.340 |
Why?
|
| G-Protein-Coupled Receptor Kinase 2 | 5 | 2007 | 15 | 0.340 |
Why?
|
| Dopamine Antagonists | 4 | 2019 | 50 | 0.330 |
Why?
|
| Transcription, Genetic | 1 | 2015 | 1702 | 0.330 |
Why?
|
| Benzazepines | 4 | 2019 | 64 | 0.320 |
Why?
|
| Receptors, Dopamine | 1 | 2008 | 40 | 0.310 |
Why?
|
| RNA, Messenger | 1 | 2015 | 2809 | 0.310 |
Why?
|
| Rats, Inbred F344 | 6 | 2012 | 105 | 0.290 |
Why?
|
| Vasoconstrictor Agents | 1 | 2008 | 137 | 0.290 |
Why?
|
| Physical Exertion | 1 | 2007 | 81 | 0.280 |
Why?
|
| Enzyme Activation | 4 | 2011 | 617 | 0.280 |
Why?
|
| GTP-Binding Protein alpha Subunits, Gq-G11 | 1 | 2007 | 18 | 0.280 |
Why?
|
| Reactive Oxygen Species | 3 | 2020 | 479 | 0.280 |
Why?
|
| Hyperglycemia | 2 | 2006 | 221 | 0.270 |
Why?
|
| Blood Glucose | 6 | 2006 | 1119 | 0.260 |
Why?
|
| Hyperinsulinism | 4 | 2010 | 68 | 0.250 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2007 | 340 | 0.250 |
Why?
|
| Mitochondria | 2 | 2020 | 677 | 0.250 |
Why?
|
| Hydrogen Peroxide | 1 | 2005 | 113 | 0.240 |
Why?
|
| Heterotrimeric GTP-Binding Proteins | 1 | 2004 | 28 | 0.230 |
Why?
|
| Natriuretic Agents | 1 | 2003 | 31 | 0.220 |
Why?
|
| Stilbenes | 2 | 2015 | 35 | 0.210 |
Why?
|
| Endothelial Cells | 1 | 2007 | 527 | 0.210 |
Why?
|
| Enzyme Inhibitors | 4 | 2020 | 571 | 0.210 |
Why?
|
| Diabetes Mellitus, Experimental | 1 | 2003 | 135 | 0.210 |
Why?
|
| Thiazoles | 1 | 2002 | 97 | 0.200 |
Why?
|
| Cell Line | 4 | 2020 | 2771 | 0.180 |
Why?
|
| Kelch-Like ECH-Associated Protein 1 | 1 | 2020 | 30 | 0.180 |
Why?
|
| Protein Disulfide-Isomerases | 1 | 2020 | 37 | 0.180 |
Why?
|
| Disease Models, Animal | 6 | 2015 | 4285 | 0.180 |
Why?
|
| Oxidation-Reduction | 2 | 2019 | 444 | 0.180 |
Why?
|
| Muscle, Smooth, Vascular | 2 | 2014 | 239 | 0.160 |
Why?
|
| Nitric Oxide Synthase Type III | 2 | 2011 | 220 | 0.160 |
Why?
|
| Physical Conditioning, Animal | 2 | 2010 | 91 | 0.160 |
Why?
|
| Cell Membrane | 3 | 2007 | 459 | 0.150 |
Why?
|
| Lysosomes | 1 | 2019 | 232 | 0.150 |
Why?
|
| TRPC Cation Channels | 1 | 2018 | 22 | 0.150 |
Why?
|
| Mitogen-Activated Protein Kinases | 2 | 2008 | 206 | 0.140 |
Why?
|
| Adenylyl Cyclases | 2 | 2007 | 75 | 0.140 |
Why?
|
| Protein Transport | 3 | 2010 | 369 | 0.140 |
Why?
|
| Gene Expression Regulation | 3 | 2020 | 2526 | 0.130 |
Why?
|
| Biphenyl Compounds | 3 | 2011 | 56 | 0.120 |
Why?
|
| Tetrazoles | 3 | 2011 | 63 | 0.120 |
Why?
|
| NADPH Oxidases | 3 | 2011 | 114 | 0.120 |
Why?
|
| Drinking | 3 | 2015 | 34 | 0.120 |
Why?
|
| Benzimidazoles | 3 | 2011 | 129 | 0.120 |
Why?
|
| Thiocyanates | 1 | 2013 | 10 | 0.110 |
Why?
|
| Sulfoxides | 1 | 2013 | 10 | 0.110 |
Why?
|
| Apoptosis | 1 | 2020 | 1781 | 0.110 |
Why?
|
| Isothiocyanates | 1 | 2013 | 13 | 0.110 |
Why?
|
| Rats, Inbred SHR | 4 | 2015 | 64 | 0.110 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2015 | 810 | 0.110 |
Why?
|
| Cells, Cultured | 3 | 2014 | 3042 | 0.100 |
Why?
|
| Calcium | 1 | 2018 | 1096 | 0.100 |
Why?
|
| NADPH Oxidase 2 | 2 | 2010 | 40 | 0.100 |
Why?
|
| Thiocarbamates | 2 | 2014 | 5 | 0.100 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2008 | 1682 | 0.100 |
Why?
|
| Transcription Factor RelA | 1 | 2012 | 53 | 0.100 |
Why?
|
| Proline | 2 | 2014 | 73 | 0.090 |
Why?
|
| Polymerase Chain Reaction | 1 | 2015 | 1584 | 0.090 |
Why?
|
| Radioimmunoassay | 1 | 2011 | 109 | 0.090 |
Why?
|
| Arginine | 2 | 2011 | 303 | 0.090 |
Why?
|
| Homeostasis | 2 | 2012 | 682 | 0.090 |
Why?
|
| Body Weight | 3 | 2015 | 1001 | 0.090 |
Why?
|
| Membrane Glycoproteins | 2 | 2010 | 412 | 0.080 |
Why?
|
| Hypoglycemic Agents | 2 | 2004 | 426 | 0.080 |
Why?
|
| Janus Kinase 2 | 1 | 2011 | 136 | 0.080 |
Why?
|
| Rats, Inbred WKY | 3 | 2015 | 54 | 0.080 |
Why?
|
| Amidohydrolases | 1 | 2009 | 18 | 0.080 |
Why?
|
| Oxidoreductases | 1 | 2009 | 92 | 0.080 |
Why?
|
| Age Factors | 2 | 2008 | 2803 | 0.080 |
Why?
|
| Blotting, Western | 2 | 2012 | 1100 | 0.080 |
Why?
|
| Focal Adhesion Kinase 2 | 1 | 2008 | 7 | 0.080 |
Why?
|
| Protein Carbonylation | 1 | 2008 | 7 | 0.080 |
Why?
|
| Analysis of Variance | 1 | 2011 | 1008 | 0.080 |
Why?
|
| Inositol 1,4,5-Trisphosphate | 1 | 2008 | 13 | 0.080 |
Why?
|
| Cyclic GMP | 1 | 2008 | 92 | 0.080 |
Why?
|
| Aorta | 2 | 2014 | 542 | 0.080 |
Why?
|
| Membranes | 1 | 2007 | 23 | 0.080 |
Why?
|
| Lipopolysaccharides | 1 | 2009 | 290 | 0.070 |
Why?
|
| Opossums | 1 | 2007 | 12 | 0.070 |
Why?
|
| Thioctic Acid | 1 | 2007 | 8 | 0.070 |
Why?
|
| Phosphatidylinositol 4,5-Diphosphate | 1 | 2007 | 13 | 0.070 |
Why?
|
| Cardiotonic Agents | 1 | 2008 | 135 | 0.070 |
Why?
|
| Alkaline Phosphatase | 1 | 2007 | 96 | 0.070 |
Why?
|
| MAP Kinase Signaling System | 1 | 2008 | 315 | 0.070 |
Why?
|
| Protein Binding | 2 | 2012 | 1741 | 0.070 |
Why?
|
| Streptozocin | 1 | 2006 | 24 | 0.070 |
Why?
|
| Injections, Intravenous | 1 | 2006 | 252 | 0.060 |
Why?
|
| Lipid Peroxidation | 1 | 2006 | 82 | 0.060 |
Why?
|
| Phorbol Esters | 1 | 2005 | 22 | 0.060 |
Why?
|
| Antihypertensive Agents | 1 | 2008 | 398 | 0.060 |
Why?
|
| Water | 1 | 2006 | 182 | 0.060 |
Why?
|
| C-Reactive Protein | 1 | 2007 | 406 | 0.060 |
Why?
|
| Cardiovascular System | 1 | 2006 | 99 | 0.060 |
Why?
|
| Stress, Physiological | 1 | 2006 | 258 | 0.060 |
Why?
|
| Colforsin | 1 | 2004 | 48 | 0.060 |
Why?
|
| Urine | 1 | 2004 | 88 | 0.060 |
Why?
|
| Protein Kinase C-delta | 1 | 2003 | 17 | 0.060 |
Why?
|
| Protein Kinase C beta | 1 | 2003 | 21 | 0.050 |
Why?
|
| Organ Culture Techniques | 1 | 2003 | 154 | 0.050 |
Why?
|
| Binding, Competitive | 1 | 2002 | 180 | 0.050 |
Why?
|
| Tritium | 1 | 2002 | 173 | 0.050 |
Why?
|
| Precipitin Tests | 1 | 2002 | 151 | 0.050 |
Why?
|
| Models, Biological | 1 | 2007 | 1444 | 0.050 |
Why?
|
| Models, Animal | 1 | 2003 | 464 | 0.050 |
Why?
|
| Eating | 2 | 2015 | 372 | 0.050 |
Why?
|
| Nerve Tissue Proteins | 1 | 2007 | 1114 | 0.050 |
Why?
|
| Active Transport, Cell Nucleus | 1 | 2020 | 113 | 0.040 |
Why?
|
| Down-Regulation | 1 | 2002 | 697 | 0.040 |
Why?
|
| Diet | 1 | 2007 | 1126 | 0.040 |
Why?
|
| Transcription Factors | 1 | 2009 | 2585 | 0.040 |
Why?
|
| Insulin Resistance | 1 | 2004 | 639 | 0.040 |
Why?
|
| RNA Interference | 1 | 2020 | 496 | 0.040 |
Why?
|
| Glucose | 1 | 2002 | 872 | 0.040 |
Why?
|
| Biomarkers | 1 | 2007 | 2943 | 0.040 |
Why?
|
| Humans | 6 | 2020 | 123092 | 0.040 |
Why?
|
| Energy Metabolism | 1 | 2020 | 770 | 0.030 |
Why?
|
| Vasoconstriction | 1 | 2014 | 104 | 0.030 |
Why?
|
| Glutathione Peroxidase | 1 | 2012 | 32 | 0.020 |
Why?
|
| G-Protein-Coupled Receptor Kinases | 1 | 2011 | 5 | 0.020 |
Why?
|
| NG-Nitroarginine Methyl Ester | 1 | 2011 | 59 | 0.020 |
Why?
|
| Mice, Inbred C57BL | 1 | 2020 | 4356 | 0.020 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2012 | 458 | 0.020 |
Why?
|
| Random Allocation | 1 | 2012 | 427 | 0.020 |
Why?
|
| Tyrosine | 1 | 2011 | 152 | 0.020 |
Why?
|
| Dinoprost | 1 | 2010 | 28 | 0.020 |
Why?
|
| Receptor, Angiotensin, Type 2 | 1 | 2011 | 39 | 0.020 |
Why?
|
| Reference Values | 1 | 2012 | 697 | 0.020 |
Why?
|
| Albuminuria | 1 | 2010 | 91 | 0.020 |
Why?
|
| Organ Size | 1 | 2011 | 412 | 0.020 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2012 | 510 | 0.020 |
Why?
|
| Transfection | 1 | 2012 | 1068 | 0.020 |
Why?
|
| Heme Oxygenase-1 | 1 | 2009 | 34 | 0.020 |
Why?
|
| Phosphates | 1 | 2009 | 112 | 0.020 |
Why?
|
| Proteinuria | 1 | 2009 | 110 | 0.020 |
Why?
|
| Binding Sites | 1 | 2012 | 1291 | 0.020 |
Why?
|
| Superoxide Dismutase | 1 | 2009 | 139 | 0.020 |
Why?
|
| Endothelium, Vascular | 1 | 2011 | 514 | 0.020 |
Why?
|
| Genetic Vectors | 1 | 2012 | 940 | 0.020 |
Why?
|
| Heart Rate | 1 | 2010 | 586 | 0.020 |
Why?
|
| Heart | 1 | 2011 | 723 | 0.020 |
Why?
|
| Mice | 1 | 2020 | 17541 | 0.010 |
Why?
|
| Risk Factors | 1 | 2012 | 10013 | 0.010 |
Why?
|